The translation initiation factor, eIF4E, is commonly overexpressed in solid tumors. This elevation allows for efficient translation of mRNA that are normally repressed by their 5 0 untranslated region, many of which encode growth -promoting proteins. This property was exploited to modulate the synthesis of HTK at the translational level to selectively kill cancer cells. Various breast cancer cell lines can efficiently synthesize HTK from the translationally regulated mRNA, whereas normal cells cannot. Accordingly, only cancer cells were killed at low concentrations of ganciclovir. By altering the expression of eIF4E, it was possible to modulate the sensitivity of various cell lines to ganciclovir.
T he use of suicide genes is one of the most promising strategies for gene therapy of solid tumors. Use of the herpes simplex virus type -1 thymidine kinase gene ( HTK ), in combination with the drug ganciclovir (GCV ), is the most commonly used cancer gene therapy system utilized to date, both in experimental models and clinical trials. 1 HTK, whose substrate specificity is distinct from cellular thymidine kinases, can convert GCV to the toxic phosphorylated form, allowing specific killing of the cells that express it. 2 To direct the expression of HTK primarily to cancer cells, most of the works have been based either on specific transcriptional regulation, or at designing methods of specific delivery. Two examples of the former strategy are the use of tissue -specific promoters 3 and inducible promoters. 4 Unlike these approaches which require specific knowledge of the cancer cells, we designed a novel strategy targeting a general characteristic that distinguishes cancer cells from normal cells, i.e., elevated eIF4E expression. Overexpression of eIF4E has been shown to be ubiquitous in solid tumors, including bladder, 5 breast, 6 cervical, 7 colon, 8 head and neck, 9 and prostate, 10 as well as many malignant cell lines. 11 -13 The availability of eIF4E, the cap -binding protein, for mRNA recruitment to the ribosomes constitutes one of the most limiting parameters in translation initiation. eIF4E is a component of the machinery that unwinds excess structure in the 5 0 untranslated region (UTR ) of mRNA. 14 Elevating eIF4E rescues the translation of repressed mRNA with long, complex 5 0 UTRs, many of which encode factors required for proliferation. 15 This property was exploited to repress the expression of HTK translationally by placing a highly structured 5 0 UTR in front of its open reading frame. The idea behind this is that cancer cells, which have higher levels of eIF4E and hence helicase activity, would be able to translate this hybrid HTK mRNA ( UTK ) whereas normal cells would not. To accomplish this, the 5 0 UTR of basic fibroblast growth factor ( FGF -2), an important angiogenic factor previously found to be translationally regulated, 16 was chosen. We show herein that cancer cell lines can translate the UTK mRNA and thus synthesize the HTK protein, in contrast to normal lines. This resulted in differential sensitivity to GCV.
Methods

Plasmids and transfection of cell lines
A 3-kb XhoI-SpeI fragment containing the HTK cDNA was cloned into BK -Shuttle episomal vector. 17 This construct is referred to as BK -TK. In the BK -UTK vector, the HTK is preceded by 619 bases of the 5 0 UTR of rat FGF -2 cDNA ( described in Shimasaki et al 18 ). This was isolated as a XhoI-BamHI fragment from plasmid rFGF( T3 ). 16 To overexpress eIF4E (referred to as eIF4E-S ), the eIF4E cDNA was cloned into KpnI and NotI of the pREP7 episomal vector (Invitrogen, Carlsbad, CA ). To reduce the eIF4E expression (referred to as eIF4E -AS ), an antisense eIF4E construct 19 was subcloned into the pREP7 vector also as a KpnI and NotI fragment.
All transfections were performed with the GenePORTER reagent ( Gene Therapy Systems, San Diego, CA ). Stable cell lines were obtained by selection with G418 for the BK constructs, and Hygromycin B for the pREP7 vectors.
Cell lines
The MM2MT, MM3MG, MCF7, MCF -10A, MDA -MB -231, and MDA -MB -435S cell lines were purchased from the American Type Culture Collection ( ATCC, Manassas, VA ). All cell lines, except MCF -10A, were grown in DMEM high -glucose media (Gibco-BRL, Grand Island, NY ), and supplemented with 10% fetal calf serum, nonessential amino acids ( Gibco -BRL ), and antibioticantimycotics ( Gibco -BRL ). The MCF-10A cells were grown in serum -free mammary epithelial growth medium ( Clonetics, San Diego, CA ) supplemented with 100 ng/ mL cholera toxin ( Calbiochem, San Diego, CA ). All cells were maintained at 378C in 5% CO 2 .
Western analysis of cell lysates
From each sample, 20 g of protein was run on 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis ( SDS -PAGE ) gels. After SDS -PAGE, the proteins were transferred to an Immobilon -P membrane ( Millipore, Bedford, MA ).
The membrane was blocked with 5% milk in TBT (0.1% Tween -20 in TBS ) for 1 hour at room temperature and then washed for 10 minutes three times with TBT. A primary rabbit polyclonal anti -eIF4E antibody was then added at a 1:1000 dilution and incubated for 1 hour. Following the same wash procedure as above, secondary anti -rabbit IgG peroxidase conjugate (Vector, Burlingame, CA ) was added at a 1:1000 dilution for 1 hour. The membrane was then washed three times with TBT for 10 minutes and developed using diamino -benzidine ( BioRad Laboratories, Richmond, CA ). For internal standardization, The membrane was then probed with a monoclonal anti -actin antibody ( Sigma, St. Louis, MO ), to which the level of eIF4E was normalized, using the same protocol as above with the following changes. Secondary anti -rabbit IgG alkaline phosphatase conjugate ( Vector ) was used, and the blot was developed using BCIP /NBT color development substrate (Promega, Madison, WI ). For the HTK Westerns, primary polyclonal anti-HTK antibody (a gift of Dr Bernard Roizman, University of Chicago ) was added at a 1:500 dilution and 6 cells by alkaline lysis, followed by phenol extraction, and separation on 1% agarose gel. C: Northern blot of HTK mRNA expressed in transfected normal ( MM3MG ) and cancer ( MM2MT ) mouse mammary cell lines. Fifteen micrograms of total RNA was fractionated on a 1.5% agarose gel, and the blot was probed with 32 P -labeled HTK cDNA. EtBr staining used to normalize for small differences in RNA loading is shown.
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Selective killing of cancer cells RJ DeFatta et al incubated for 1 hour. Again, the membranes were then probed with actin for internal standardization (Sigma ), to which the level of HTK was normalized using the same protocol as stated above. Each Western blot was performed in triplicate. Each repetition was performed on a different frozen aliquot from each cell line to account for any variability within the characteristics of the cells from one passage to another.
Cell viability assay
Cells were plated at a density of 10 3 cells per well in 24-well plates. Twenty-four hours later, the medium was removed and fresh medium containing various concentrations of GCV was added. Every 48 hours, the medium containing GCV was replaced. After 14 days, cell proliferation and viability were measured spectrophotometrically at 490 nm following staining with ''Aqueous CellTiter 96
1 Aqueous One Solution Cell Proliferation Assay'' ( Promega). Each experiment was performed at least three times. The ED 50 was extrapolated from the plots, and the selective index was determined as the ratio of nonspecific toxicity ( ED 50 of untransfected cells) to that of HTK -transfected cells.
Results
The expression of HTK is translationally repressed in normal, but not cancer, cell lines
We chose to use the BK -Shuttle vector, which allows for high -copy episomal expression, 17 to drive the expression of the HTK gene. Figure 1A depicts the normal HTK cDNA ( BK -TK ) and the hybrid HTK ( BK -UTK ) constructs. Note the addition of the 619 bp from the rat FGF -2 5 0 UTR shown as a hairpin with a predicted stability of À 55 kcal /mol, which was previously shown to be highly inhibitory to capdependent translation. 16 Each vector was stably transfected, by G418 selection, into either MM3MG cells ( a normal mouse mammary line ) or MM2MT cells (a mouse mammary carcinoma line ). Hirt's supernatant extraction of the episomes from the different cell lines revealed equal copy number, and hence presumably equal gene dosage (Fig 1B ) . A Northern blot indicated that the expression of HTK mRNA was approximately the same in each cell line, irrespective of the 5 0 UTR, after accounting for loading differences ( Fig  1C) . A different result was obtained when expression of the HTK protein was analyzed by Western blot. Robust HTK expression was seen in MM3MG cells transfected with the BK -TK vector, but only minimal ( at least 12 -fold less; P < .01 ) expression from the BK -UTK vector ( Fig 2A,  compare lanes 2 and 3 ) . In contrast, the MM2MT cells transfected with either vector showed similar expression of the HTK protein (lanes 6 and 8 ). No HTK immunoreactive band was seen in the untransfected cells (lanes 1 and 5 ) . Note that the expression of eIF4E was 4-fold higher in MM2MT than that in MM3MG, after normalization to actin ( Table 1 ). This indicates that the expression of HTK is under translational regulation and that the elevated eIF4E in the cancer cells may allow them to overcome the inhibitory effect of the 5 0 UTR. To determine if the differential synthesis of the HTK protein from the UTK mRNA was largely a direct consequence of the level of eIF4E, the MM3MG -UTK cells Figure 2 Western blot analysis of the expression of HTK in the different transfectants, correlation to the level of eIF4E, and sensitivity to GVV. A: Twenty micrograms of total protein from each sample was run on 10% SDS -PAGE gels, transferred to Immobilon -P membranes, and probed with either anti -eIF4E, antiactin, or anti -HTK ( a kind gift of Dr Bernard Roizman, University of Chicago ) rabbit sera. ( À ) Indicates untransfected, parental cells ( lanes 1 and 5 ) . B: Killing curves by GCV treatment. The indicated stable transfectants were incubated for 14 days with the indicated amounts of GCV. ( Fig  2A, lane 4 ) . (The vector, pRep7, is hygromycin -selectable; Invitrogen ). The level of eIF4E was increased 3 -fold when compared to parental cells. This resulted in a large increase in HTK protein from the BK -UTK vector, comparable to that expressed in the MM3MG -TK cells ( lanes 2 and 4 vs lane 3 ). In addition, the MM2MT-TK and MM2MT-UTK cell lines were transfected with a vector expressing antisense RNA to eIF4E (Fig 2A, lanes 7 and 9 ) . This resulted in a 2-fold reduction in the level of eIF4E in these cells compared to parental MM2MT ( P <.05 ). The reduction of eIF4E in the MM2MG -TK /4E -AS cells had only a minimal effect on the synthesis of HTK (lane 7 ), and the synthesis of most proteins was also not affected by this (data not shown ). However, there was a 13-fold reduction in HTK protein in the MM2MT-UTK /4E -AS cells ( lane 9 vs 8; P < .01).
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These results confirm that the translation of the UTK mRNA is strongly dependent on the level of eIF4E, which is commonly elevated in cancer cells.
Differential expression of HTK from the BK -UTK vector results in selective sensitivity to GCV
All the MM3MG and MM2MT derived cell lines were incubated with various concentrations of GCV ( 0.01-1000 M) for 14 days, and cell viability was then determined ( Fig  2B ) . A summary of the toxic effects, expressed as ED 50 , as well as the levels of eIF4E and HTK expression in each cell line is provided in Table 1 . A dose -response curve showed that the MM3MG -TK cells were sensitive to low concentrations of GCV (0.1 M), whereas the untransfected cells were nonspecifically inhibited at a much higher concentration (!200 M ). Most importantly, the sensitivity of MM3MG -UTK cells to GCV was similar to the untransfected cells, reflecting the low expression of HTK in these cells. Overexpressing eIF4E in these cells (MM3MG -UTK / 4E-S ) greatly increased their sensitivity to GCV.
A different result was obtained with MM2MT cells. The ED 50 revealed that the MM2MT-TK cells and MM2MT-UTK were killed at nearly the same low concentration of GCV ( Table 1 ). However, when the level of eIF4E was reduced with antisense RNA ( MM2MT-UTK /4E -AS ), a 370-fold higher concentration of GCV was required for comparable killing. In contrast, the MM2MT-TK /4E -AS cells were sensitive to the same concentration of GCV as the parental MM2MT-TK. This confirms that the level of eIF4E modulates the translatability of the UTK mRNA and, therefore, sensitivity to GCV.
HTK expression and GCV sensitivity in human breast cell lines
Because it has been shown that some cells are intrinsically more resistant to the HTK /GCV system, 20 we wanted to determine if the selective killing of cancer cells could be extended to a panel of human breast cell lines. One normal yThe level of eIF4E in the various cell lines was arbitrarily expressed relative to untransfected MM3MG cells. The average expression from Western blots of three separate extract preparations of each line is indicated.
zThe expression of HTK was arbitrarily compared to that of MM3MG transfected with BK -TK. The average expression from Western blots of three separate extract preparations of each line is indicated. Figure 3 HTK expression in transfected human breast cell lines. A: Western blot. Twenty micrograms of total protein from each sample was run on 10% SDS -PAGE gels, transferred to Immobilon -P membranes, and probed sequentially with anti -HTK and anti -actin. B: Recovery of episomes from the various transfected cells. Plasmids were recovered from 2Â10 5 cells by alkaline lysis, followed by phenol extraction, and separation on 1% agarose gel. Note that the topomeric forms of the plasmid were different in the various cell lines.
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Selective killing of cancer cells RJ DeFatta et al breast cell line (MCF -10A ) and three human breast cancer cell lines (MCF7, MDA -231, and MDA -435S ) were transfected with both the BK -TK and the BK -UTK vectors. The cancer cell lines have at least a 3 -fold higher level of eIF4E than the MCF -10A cells and 10-fold higher than a primary culture of normal breast epithelial cells 12 ( data not shown). Figure 3 shows the expression of HTK in each cell line and the corresponding actin level. Note that MCF -10A transfected with BK -UTK is the only cell line that showed drastically reduced synthesis of HTK. Also note that the vector copy number is similar in all the transfected lines, ( Fig 3B ) and thus, differences in HTK expression are unlikely to be due to differences in gene dosage in the different cell lines.
Next, we examined if the elevated expression of HTK from the BK -UTK vector renders the human breast cancer cells more susceptible to GCV-mediated cell killing than the normal MCF -10A cell line. Thus, all the cell lines were incubated with various concentrations of GCV (0.001 -10 mM ) for 14 days and the cell viability was determined. Table 2 shows that the MCF -10A -TK cells were killed at 0.3 mM GCV, but the MCF -10A -UTK were no more sensitive to GCV than the untransfected MCF -10A parental cells. In contrast to MCF-10A cells, MCF7 cells transfected with either BK -TK or BK -UTK were killed at about the same low GCV concentration (0.02 and 0.01 mM, respectively ). The selective indexes were 300 and 600 ( Table 2 ) , which correspond well to the equivalent expression of HTK ( Fig 3A, lanes 4 and 5 ) . The same was true for MDA -435S cells (Table 2 ). This again shows that cancer cell lines, which can synthesize HTK equally well from either the BK -TK or BK -UTK vectors, are sensitive to GCV. The exception was with the MDA -231 cells. Although both the MDA -231-TK and MDA -231-UTK cells synthesized HTK equally well ( Fig 3, lanes 6 and 7) , the cells were insensitive to GCV, except for nonspecific toxicity at 5 mM ( Table 2 ) . Although this result was unexpected, similar results and variability in GCV sensitivity have previously been reported. 20 -22,23 One possibility is that these cells may have acquired a noncanonical (non -Pgp ) multidrug resistance, 24 rendering them insensitive to GCV. In fact, this cell line was developed from a patient that had been treated with adriamycin, which was previously shown to confer the MDR phenotype.
25,26
Discussion
Immune stimulation, replacement of tumor suppressors, antisense RNA, and therapy with suicide genes are the four major categories of gene therapy for solid tumors. Of these, the HTK / GCV approach is the most commonly used system utilized to date, both in experimental settings and clinical trials. 1 In fact, since the concept of HTK / GCV system was first described, 27 it has shown good success as a tumor ablation strategy in a variety of experimental models. In addition, over two dozen clinical gene therapy trials based on this model have been initiated in the last few years. 28 -30 The HTK /GCV system is appealing due to the low inherent toxicity of the system. Moreover, it has been shown that when as few as 10% of the cancer cells expresses the HTK gene, it is possible to obtain complete tumor ablation due to the bystander effect and specific immune responses. 31 One of the main obstacles to gene therapy modalities is the inability to successfully target cancer cells, whereas at the same time not harming normal cells. Indeed, it has been shown that even when therapeutic vectors are delivered locally to a primary tumor, systemic effects still occur, indicating that the vector has become bloodborne. 32, 33 One approach to circumvent this problem is through the use of elements allowing specific transcriptional regulation of the vector, e.g., the use of tissuespecific promoters 3 and inducible promoters. 4 Whereas these approaches are very promising, they require specific knowledge of the cancer cells, and are not applicable to most situations.
Unlike these approaches, this work is based on a general characteristic that distinguishes cancer cells from normal cells, i.e., elevated eIF4E expression. In this study, we have shown that through the use of a translationally regulated HTK mRNA ( BK -UTK vector ), the expression of the HTK protein could be largely inhibited in normal cells. In contrast, cancer lines were capable of efficient translation of the UTK mRNA. Altering the expression of eIF4E in these cells had a direct impact on the translation of the UTK mRNA and the pattern of GCV sensitivity. It is anticipated that better delivery and targeting the UTK -expressing vector to cancer cells will still be important in vivo, as it is conceivable that toxicity may occur to some types of normal cells that have unusually higher eIF4E expression level (possibly stem cells).
In conclusion, the results obtained in this study give compelling evidence to further the evaluation of the use of translational regulation to modulate the expression of a suicide gene in experimental cancer gene therapy.
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